Studies Conducted at Fox Chase Cancer Center on Leiomyosarcoma Recently Published [SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS)]

Press/Media

PeriodDec 4 2023

Media coverage

1

Media coverage

  • TitleStudies Conducted at Fox Chase Cancer Center on Leiomyosarcoma Recently Published [SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS)]
    Media name/outletClinical Trials Daily
    Country/TerritoryUnited States
    Date12/4/23
    PersonsLori A. Rink, Douglas B. Flieder, Yan Zhou, Margaret von Mehren
View all 1
View less

Related content